Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D000998:Antiviral Agents